Akkermansia finally as Supplment available

I don’t receive any compensation for this specific product advertisement below, but when something has been remarkably helpful, I believe it is important to **share it among colleagues**. Many of these “nuggets of practical advice” can be found under my **Practice Snippets** (separate menu). In this article, I am promoting a new postbiotic and showcasing studies on the topic.

Akkermansia: The Most Important Microbe in the Gut

Steven Gundry constantly speaks about Akkermansia, the microbe that lives in the crypts of the gut (small mucosal recesses), where it produces mucus, thereby nourishing and protecting the intestinal lining.

Here is the book Gut Check, which is currently only available in English: Amazon-Link dazu

Here is a YouTube video where Steven Gundry discusses Akkermansia

“Practice Snippet” on Akkermansia

I recently saw a patient with intestinal MCAS who had been suffering from severe diarrhea for years; nothing had really helped until now (except for finally being diagnosed by a doctor and receiving the appropriate antihistamines).

However, things are truly improving now that she has been using the following product for 6 weeks:

Akkermansia ProBio-Cult AKK1

An innovative postbiotic for the targeted promotion of Akkermansia muciniphila.

Akkermansia ProBio-Cult AKK1 is a modern postbiotic specifically designed to support the growth and activity of Akkermansia muciniphila in the gut—one of the most intensively researched gut bacteria today in the context of metabolism, inflammation, and barrier function.

Especially in integrative medicine, Akkermansia is gaining significance, as low levels of this bacterium are associated with a variety of chronic conditions, including:

• Metabolic syndrome
• Obesity
• Insulin resistance
• Chronic inflammatory processes
• Intestinal barrier disorders
• Mast cell activation (MCAS)

In my practice, this product led to a significant and sustainable stabilization in a patient with severe MCAS-related diarrhea—a clinical indication of the relevance of the intestinal barrier and mucosal immune regulation.

What is Akkermansia muciniphila?

Akkermansia muciniphila is a Gram-negative, anaerobic bacterium that lives in the mucus layer of the intestine. It feeds on mucin while simultaneously stimulating its production—a fascinating symbiotic mechanism.

Key Functions:

• Promoting intestinal mucosal integrity
• Stimulating tight junctions
• Reducing systemic inflammation
• Improving metabolic parameters
• Modulating the immune response (e.g., Tregs)

A low percentage of Akkermansia is now considered a marker for a compromised gut barrier.

A Postbiotic Approach Instead of a Classic Probiotic

The unique feature of AKK1 is the postbiotic approach. Instead of primarily administering live bacteria, it targets metabolic products or bacterial components that:

• Promote the endogenous Akkermansia population
• Modulate the mucosal immune response
• Exert anti-inflammatory effects

This is particularly advantageous for sensitive patients—such as those with MCAS or dysbiosis—as live microbes are not always well-tolerated.

Current Research on Akkermansia

Scientific evidence regarding Akkermansia muciniphila has grown significantly in recent years.

Human Studies

Depommier et al., 2019, Nature Medicine
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers

• Pasteurized Akkermansia improved insulin sensitivity
• Reduction in inflammatory markers
• Improvement in metabolic parameters
• Excellent tolerability

This study was a milestone, as it demonstrated that even pasteurized (inactive) Akkermansia can be biologically highly effective—a crucial point in favor of postbiotic strategies.

Mechanistic Studies

Numerous preclinical studies show:

• Improvement of the intestinal barrier
• Reduction of endotoxemia
• Influence on GLP-1 and metabolic signaling pathways
• Modulation of the immune system

In particular, the outer membrane protein Amuc_1100 appears to be immunomodulatorily active.

Relevance in MCAS and Chronic Inflammation

In Mast Cell Activation Syndrome (MCAS), we frequently observe:

• Compromised mucosal barrier
• Increased permeability (Leaky Gut)
• Immunological imbalance
• Dysbiosis with reduced diversity

Akkermansia can intervene here on several levels:

• Stabilizing the mucus layer
• Reducing bacterial translocation
• Indirectly calming mast cells through barrier strengthening
• Promoting regulatory immune mechanisms
• Particularly in cases of chronic diarrhea, the regeneration of mucosal integrity can be therapeutically decisive.

Why This Product is Noteworthy

• One of the first systematic attempts to modulate Akkermansia via a targeted postbiotic approach
• Suitable even for highly sensitive patients
• High scientific plausibility
• Good tolerability
• Potentially broad range of applications: metabolic, immunological, inflammatory

Summary for Colleagues

Akkermansia ProBio-Cult AKK1 represents an innovative postbiotic approach to promoting Akkermansia muciniphila.

Given the growing evidence regarding the importance of this bacterium for:

• Intestinal barrier function
• Immune modulation
• Metabolic regulation
• Chronic inflammation

this product can be a valuable addition to integrative therapy concepts—especially in cases of dysbiosis, metabolic syndrome, MCAS, or chronic inflammatory bowel diseases.

Based on my clinical experience, this approach deserves significantly more attention—particularly in the context of immunological and mast-cell-driven disorders.